Document Detail


Gabapentin use in hyperemesis gravidarum: a pilot study.
MedLine Citation:
PMID:  20015600     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Among 7 subjects with hyperemesis gravidarum (HG), we found gabapentin therapy to be associated with mean reductions in nausea and emesis from Baseline to Days 12-14 of 80% and 94%, respectively. There have been 2 congenital defects among 7 exposed infants. Gabapentin may be effective in the treatment of HG.
Authors:
Thomas Guttuso; Luther K Robinson; Kofi S Amankwah
Publication Detail:
Type:  Journal Article     Date:  2009-12-16
Journal Detail:
Title:  Early human development     Volume:  86     ISSN:  1872-6232     ISO Abbreviation:  Early Hum. Dev.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-02-17     Completed Date:  2010-05-03     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  65-6     Citation Subset:  IM    
Affiliation:
Department of Neurology, University at Buffalo, 3435 Main Street, 311 BRB, Buffalo, NY 14214, USA. tguttuso@buffalo.edu <tguttuso@buffalo.edu>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amines / therapeutic use*
Cyclohexanecarboxylic Acids / therapeutic use*
Female
Humans
Hyperemesis Gravidarum / drug therapy*
Pilot Projects
Pregnancy
Treatment Outcome
gamma-Aminobutyric Acid / therapeutic use*
Chemical
Reg. No./Substance:
0/Amines; 0/Cyclohexanecarboxylic Acids; 56-12-2/gamma-Aminobutyric Acid; 6CW7F3G59X/gabapentin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study.
Next Document:  Sexual dysfunction and the ageing male.